Tag Archives: US Senate Finance Committee

Avandia Trial in Trouble

GSK’s Avandia just won’t stay out of the news. Now comes a report from The Wall Street Journal that the FDA is considering dealing the beleaguered diabetes drug another blow by stopping one of its safety trials. The TIDE trial, which received approval in 2007, pits Avandia (rosiglitazone) against Takeda’s Actos (pioglitazone), a drug that […]
Posted in Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta